Bouvel Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
45,853
-709
-2% -$38.5K 0.44% 65
2026
Q1
$2.92M Buy
46,562
+420
+0.9% +$33.6K 0.85% 44
2025
Q4
$4.4M Buy
46,142
+686
+2% +$67.3K 1.27% 33
2025
Q3
$4.44M Sell
45,456
-492
-1% -$51K 1.36% 32
2025
Q2
$4.94M Buy
45,948
+800
+2% +$80.9K 1.67% 24
2025
Q1
$3.78M Sell
45,148
-759
-2% -$76.4K 1.42% 25
2024
Q4
$4.1M Buy
45,907
+759
+2% +$66.8K 1.48% 24
2024
Q3
$3.78M Buy
45,148
+702
+2% +$55.3K 1.42% 25
2024
Q2
$3.42M Sell
44,446
-125
-0.3% -$9.15K 1.32% 29
2024
Q1
$3.05M Sell
44,571
-438
-1% -$28.2K 1.32% 30
2023
Q4
$2.6M Buy
45,009
+1,282
+3% +$68.4K 1.22% 35
2023
Q3
$2.31M Buy
43,727
+552
+1% +$28.9K 1.25% 36
2023
Q2
$2.34M Buy
43,175
+1,219
+3% +$63.7K 1.28% 34
2023
Q1
$2.1M Sell
41,956
-107
-0.3% -$5.04K 1.23% 36
2022
Q4
$1.95M Sell
42,063
-41
-0.1% -$1.77K 1.26% 33
2022
Q3
$1.63M Buy
+42,104
New +$1.69M 1.09% 38

Other funds holding BSX

Bouvel Investment Partners's BSX Position: Q2 2026 in Review

Bouvel Investment Partners reduced its Boston Scientific (BSX) stake by 1.5% in Q2 2026, selling an estimated $38.5K and leaving 45,853 shares worth $1.96M. The position accounts for 0.44% of the portfolio, ranked #65.

Bouvel Investment Partners first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.94M in Q2 2025. 308 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bouvel Investment Partners held 45,853 shares of Boston Scientific worth $1.96M as of Q2 2026.
  • Bouvel Investment Partners sold 709 Boston Scientific shares in Q2 2026, an estimated $38.5K.
  • Boston Scientific made up 0.44% of Bouvel Investment Partners's portfolio in Q2 2026, its #65 holding.
  • Bouvel Investment Partners first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
  • Bouvel Investment Partners's Boston Scientific position peaked at $4.94M in Q2 2025.
  • 308 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bouvel Investment Partners's 13F filing for Q2 2026, filed 17 Jul 2026.